Literature DB >> 18078885

Relative risk factors for requirement of blood transfusion after total hip arthroplasty.

Michael Walsh1, Charles Preston, Matthew Bong, Vipul Patel, Paul E Di Cesare.   

Abstract

One thousand thirty-five total hip arthroplasty (THA) cases were retrospectively reviewed, and the number and type (autologous and allogenic) of postoperative units of blood transfused were analyzed with respect to pre-, intra-, and postoperative variables. The most significant and consistent predictors of a blood transfusion after THA were advanced age and the use of low-molecular-weight heparin for deep venous thrombosis prophylaxis. Our recommendations for predonation are 1 unit for THA patients younger than 75 years if hemoglobin is 130 g/dL or greater and 2 units or a combination of 1 unit of predonated blood and 1 unit of directed or banked blood for THA patients older than 75 years.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078885     DOI: 10.1016/j.arth.2006.10.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Blood loss in cemented THA is not reduced with postoperative versus preoperative start of thromboprophylaxis.

Authors:  Pål O Borgen; Ola E Dahl; Olav Reikerås
Journal:  Clin Orthop Relat Res       Date:  2012-04-03       Impact factor: 4.176

2.  Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty.

Authors:  Shahryar Noordin; Terrence S Waters; Donald S Garbuz; Clive P Duncan; Bassam A Masri
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

3.  Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.

Authors:  Anas Saleh; Travis Small; Aiswarya Lekshmi Pillai Chandran Pillai; Nicholas K Schiltz; Alison K Klika; Wael K Barsoum
Journal:  J Bone Joint Surg Am       Date:  2014-09-17       Impact factor: 5.284

4.  Nonanemic patients do not benefit from autologous blood donation before total knee replacement.

Authors:  Stephen Kim; Eric Altneu; Jad Bou Monsef; Elizabeth A King; Thomas P Sculco; Friedrich Boettner
Journal:  HSS J       Date:  2011-06-14

5.  Nonanemic patients do not benefit from autologous blood donation before total hip replacement.

Authors:  Friedrich Boettner; Eric I Altneu; Brendan A Williams; Matthew Hepinstall; Thomas P Sculco
Journal:  HSS J       Date:  2009-12-05

6.  Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population.

Authors:  Kang-Il Kim; Dong-Geun Kang; Sumit S Khurana; Sang-Hak Lee; Young-Joo Cho; Dae-Kyung Bae
Journal:  Knee Surg Relat Res       Date:  2013-05-29

7.  Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study.

Authors:  Malin S Carling; Anders Jeppsson; Bengt I Eriksson; Helena Brisby
Journal:  J Orthop Surg Res       Date:  2015-03-28       Impact factor: 2.359

Review 8.  Patient Blood Management in Hip Replacement Arthroplasty.

Authors:  Jong Hee Lee; Seung Beom Han
Journal:  Hip Pelvis       Date:  2015-12-30

9.  Complication rates and resource utilization after total hip and knee arthroplasty stratified by body mass index.

Authors:  Justin Turcotte; McKayla Kelly; Jacob Aja; Paul King; James MacDonald
Journal:  J Orthop       Date:  2021-02-20

10.  Natural outcome of hemoglobin and functional recovery after the direct anterior versus the posterolateral approach for total hip arthroplasty: a randomized study.

Authors:  Jia Cao; Yiqin Zhou; Wei Xin; Jun Zhu; Yi Chen; Bo Wang; Qirong Qian
Journal:  J Orthop Surg Res       Date:  2020-06-01       Impact factor: 2.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.